Dosage form:injection for subcutaneous use Drug class:Interleukin inhibitors Medically reviewed byCarmen Pope, BPharm. Last updated on Oct 14, 2024. What is Dupixent? Dupixent (dupilumab) may be used to treat moderate-to-severe eczema, moderate-to-severe eosinophilic or oral-corticosteroid-dependent...
to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical...
Uncontrolled Moderate-to-SevereECZEMA (ATOPIC DERMATITIS OR AD)Ages 6+ MonthsAdd-on Maintenance Treatment for Uncontrolled Moderate-to-Severe Eosinophilic or Oral Steroid DependentASTHMAAges 6+ YearsDUPIXENT is not used to relieve sudden breathing problems and will not replace an inhaled rescue medicine...
doing so, it helps to alleviate the symptoms and prevent flare-ups associated with eczema and asthma. While it is highly effective for these purposes, its impact on weight is not well-known. For more detailed information onDupixent’s side effects, cost, and more, you can refer to ...
Eczema:injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, cold sores in your mouth or on your lips, and high count of a certain white blood cell (eosinophilia). ...
To be eligible for benefits, patients must also have a history of taking topical treatments, such as moderate corticosteroids or calcineurin inhibitors, since their diagnosis, or have a record of indicators of the severity of atopic dermatitis, such as an Eczema Area and Severity Index (EASI) sc...
Eczema: injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, dry eye, cold sores in your mouth or on your lips, and high count of a certain white blood cell (eosinophilia). Asthma: injection site reactions, high count ...